These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15025943)

  • 21. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic angiogenesis: a new treatment modality for ischemic heart disease.
    Nelson MA; Passeri J; Frishman WH
    Heart Dis; 2000; 2(4):314-25. PubMed ID: 11728275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.
    Visniauskas B; Perry JC; Gomes GN; Nogueira-Pedro A; Paredes-Gamero EJ; Tufik S; Chagas JR
    Physiol Rep; 2021 May; 9(9):e14863. PubMed ID: 33991464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
    Fukuda S; Kaga S; Zhan L; Bagchi D; Das DK; Bertelli A; Maulik N
    Cell Biochem Biophys; 2006; 44(1):43-9. PubMed ID: 16456233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
    Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
    FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo.
    Zhang H; Yuan YL; Wang Z; Jiang B; Zhang CS; Wang Q; Xu XH; Dong HY; Zhang ZM
    Gene Ther; 2013 Sep; 20(9):893-900. PubMed ID: 23514706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preconditioning--endogenous defence mechanisms of the heart during ischemia].
    Sommerschild HT
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3269-73. PubMed ID: 11187167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic angiogenesis using vascular endothelial growth factor.
    Ye L; Haider HK; Jiang SJ; Sim EK
    Asian Cardiovasc Thorac Ann; 2004 Jun; 12(2):173-81. PubMed ID: 15213090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
    Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
    Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial angiogenesis.
    Toyota E; Matsunaga T; Chilian WM
    Mol Cell Biochem; 2004 Sep; 264(1-2):35-44. PubMed ID: 15544033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.
    Payne TR; Oshima H; Okada M; Momoi N; Tobita K; Keller BB; Peng H; Huard J
    J Am Coll Cardiol; 2007 Oct; 50(17):1677-84. PubMed ID: 17950150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass grafting.
    Thourani VH; Nakamura M; Duarte IG; Bufkin BL; Zhao ZQ; Jordan JE; Shearer ST; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):383-9. PubMed ID: 9918981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis for the treatment of inoperable coronary disease: the future.
    Sellke FW; Laham R; Suuronen EJ; Ruel M
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):184-8. PubMed ID: 16959748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiogenic gene therapy for ischemic heart disease].
    Ueno H
    Nihon Rinsho; 1998 Oct; 56(10):2645-52. PubMed ID: 9796333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.
    Nishida T; Shimokawa H; Oi K; Tatewaki H; Uwatoku T; Abe K; Matsumoto Y; Kajihara N; Eto M; Matsuda T; Yasui H; Takeshita A; Sunagawa K
    Circulation; 2004 Nov; 110(19):3055-61. PubMed ID: 15520304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preconditioning the myocardium: from cellular physiology to clinical cardiology.
    Yellon DM; Downey JM
    Physiol Rev; 2003 Oct; 83(4):1113-51. PubMed ID: 14506302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.